DongKook Pharmaceutical Co., Ltd.
Financials
Valuation Metrics
DongKook Pharmaceutical Co., Ltd.'s Market Cap is ₩1.0T. At end of 2025 it was ₩7757B. Ranked #308 of 2,419 in KR market (top 13%), #87 of 1,638 on KOSDAQ (top 5%), #33 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 14%) by Market Cap.
Investment Metrics(as of 2026-10-07)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 1.03T KRW | KR#308/2,419 Sec#33/231 |
| Revenue | 979.60B KRW | KR#418/2,419 Sec#15/231 |
| Net Income | 81.46B KRW | KR#288/2,419 Sec#18/231 |
| Total Assets | 1.12T KRW | KR#452/2,419 Sec#24/231 |
| Net Assets | 797.63B KRW | KR#348/2,419 Sec#21/231 |
| Employees | 1,216 | KR#212/2,419 Sec#13/231 |
| Value | ||
| P/E | 12.63x | KR#943/2,419 Sec#51/231 |
| P/B | 1.29x | KR#1,636/2,419 Sec#105/231 |
| PEG | 0.46x | KR#682/2,419 Sec#44/231 |
| P/S | 1.05x | KR#1,403/2,419 Sec#79/231 |
| EV/EBITDA | 9.97x | KR#611/2,419 Sec#27/231 |
| FCF Yield | 2.53% | KR#1,016/2,419 Sec#62/231 |
| Profitability | ||
| ROE | 10.21% | KR#595/2,419 Sec#42/231 |
| ROA | 7.29% | KR#491/2,419 Sec#37/231 |
| Op. Margin | 10.47% | KR#496/2,419 Sec#44/231 |
| Revenue Growth | 12.73% | KR#771/2,419 Sec#75/231 |
| Earnings Growth | 27.37% | KR#665/2,419 Sec#44/231 |
| Financial Health | ||
| Debt Ratio | 40.12% | KR#790/2,419 Sec#92/231 |
| Total Debt | 67.26B KRW | KR#885/2,419 Sec#60/231 |
| FCF | 26.05B KRW | KR#447/2,419 Sec#26/231 |
| Cash | 74.46B KRW | KR#582/2,419 Sec#30/231 |
| Current Ratio | 2.05x | KR#845/2,419 Sec#95/231 |
| Net Debt/EBITDA | -0.07x | KR#587/2,419 Sec#35/231 |
| Dividend | ||
| Div. Yield | 0.88% | KR#1,138/2,419 Sec#67/231 |
| Div. Growth | 0.00% | KR—/2,419 Sec—/231 |
| Performance | ||
| 1Y Return | 18.92% | KR#452/2,419 Sec#28/231 |
| 1M Return | 9.38% | KR#566/2,419 Sec#55/231 |
| From 52W High | -27.20% | KR#489/2,419 Sec#28/231 |
| 1Y MDD | -44.68% | KR#768/2,419 Sec#60/231 |
| Trading | ||
| Volume | 608,486 shares | KR#199/2,419 Sec#28/231 |
| Trading Value | 13.99B KRW | KR#210/2,419 Sec#22/231 |
| Foreign Own. | 10.97% | KR#443/2,419 Sec#37/231 |
| Per Share | ||
| EPS | 1,801 KRW | KR#483/2,419 Sec#29/231 |
| BPS | 17,635 KRW | KR#600/2,419 Sec#39/231 |
Company Info
Dongguk Pharmaceutical, established in 1968 and listed on KOSDAQ in 2007, is a pharmaceutical company with subsidiaries including Dongguk Pharmaceutical Life Science. It manufactures and sells over-the-counter drugs, prescription drugs, and active pharmaceutical ingredients, alongside supplying cosmetics, health functional foods, and household goods domestically and internationally. The company has built a strong production base through mass production of natural material ingredients, automated warehouses, and secure manufacturing spaces. It is expanding into a global pharmaceutical company by exporting new platform technology products overseas. The company is headquartered in Gangnam-gu, Seoul.